. 2025 Jul 1.

doi: 10.1007/s00467-025-06853-8. Online ahead of print.

Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study

Angie Aguilar-González^{1

2}, Ava Zardynezhad³, Catherine Morgan⁴, Allison Dart⁵, Cherry Mammen⁶, Rulan S Parekh^{1

7}, Pavel Geier⁸, Genevieve Benoit⁹, Guido Filler¹⁰, Janusz Feber⁸, James Tee¹¹, Steven Arora¹², Damien Noone⁴, Silviu Grisaru¹³, Rahul Chanchlani¹², Augustina Okpere¹³, Susan Samuel^{14

15}

Affiliations

¹ Department of Pediatrics, SickKids, University of Toronto, Toronto, ON, Canada.
² Hospital Materno Infantil Juan Pablo II, Universidad Rafael Landivar, Guatemala City, Guatemala.
³ Faculty of Medicine and Dentistry, University of Alberta, Calgary, AB, Canada.
⁴ Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
⁵ Department of Pediatrics and Child Health, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
⁶ Division of Nephrology, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
⁷ Women's College Hospital, Toronto, ON, Canada.
⁸ Division of Nephrology, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
⁹ Division of Nephrology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Québec, Canada.
¹⁰ Division of Nephrology and Hypertension, Department of Paediatrics, London Health Sciences Centre, London, ON, Canada.
¹¹ Division of Nephrology, Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.
¹² Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
¹³ Division of Pediatric Nephrology, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Alberta, Canada.
¹⁴ Division of Nephrology, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. susan.samuel@ubc.ca.
¹⁵ Division of Nephrology, Department of Pediatrics, University of British Columbia, Room V3-337, 938 West 28 Avenue, Vancouver, BC, V6H 3V4, Canada. susan.samuel@ubc.ca.

PMID: 40590957
DOI: 10.1007/s00467-025-06853-8

Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study

Angie Aguilar-González et al. Pediatr Nephrol. 2025.

. 2025 Jul 1.

doi: 10.1007/s00467-025-06853-8. Online ahead of print.

Authors

Affiliations

¹ Department of Pediatrics, SickKids, University of Toronto, Toronto, ON, Canada.
² Hospital Materno Infantil Juan Pablo II, Universidad Rafael Landivar, Guatemala City, Guatemala.
³ Faculty of Medicine and Dentistry, University of Alberta, Calgary, AB, Canada.
⁴ Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
⁵ Department of Pediatrics and Child Health, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
⁶ Division of Nephrology, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
⁷ Women's College Hospital, Toronto, ON, Canada.
⁸ Division of Nephrology, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
⁹ Division of Nephrology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Québec, Canada.
¹⁰ Division of Nephrology and Hypertension, Department of Paediatrics, London Health Sciences Centre, London, ON, Canada.
¹¹ Division of Nephrology, Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.
¹² Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
¹³ Division of Pediatric Nephrology, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Alberta, Canada.
¹⁴ Division of Nephrology, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. susan.samuel@ubc.ca.
¹⁵ Division of Nephrology, Department of Pediatrics, University of British Columbia, Room V3-337, 938 West 28 Avenue, Vancouver, BC, V6H 3V4, Canada. susan.samuel@ubc.ca.

PMID: 40590957
DOI: 10.1007/s00467-025-06853-8

Abstract

Background: Steroid-sparing therapies are often used to prolong disease remission while minimizing steroid toxicity in childhood steroid-sensitive nephrotic syndrome (SSNS). This study aims to describe practice variation in the use of steroid-sparing medications for childhood SSNS in Canada.

Methods: Children (1-18 years) with nephrotic syndrome (NS) from eleven pediatric nephrology centers in Canada were enrolled in the Canadian Childhood Nephrotic Syndrome (CHILDNEPH) prospective cohort from 2013-2019. Data, including time to first relapse for children treated with cyclophosphamide, tacrolimus, mycophenolate mofetil, cyclosporine and rituximab were analyzed using summary statistics. Participants who received steroid-sparing therapies prior to enrolment were excluded.

Results: Of the 371 children enrolled, 321 (86.5%) had SSNS and 133 met the study criteria. Median age at enrollment was 3.0 years (IQR: 2.0-6.3). Median follow-up period was 3.0 years (IQR 1.0-4.0). Timing of initiation and choice of steroid-sparing therapy varied across centers. The majority (72.2%) initiated therapies after a median of 3 relapses (IQR: 2-4). Cyclophosphamide and tacrolimus were the most frequently used initial therapies at 39.1% and 23.3%, respectively. Thirty (22.6%) patients switched to a second medication after a median time of 4 months (IQR 0.25-11); of which, 40% switched from either cyclophosphamide or mycophenolate mofetil to tacrolimus. There were no statistically significant differences in time to first relapse with initial therapies (log rank P-value 0.36).

Conclusions: Significant variation in the use of steroid-sparing therapies exists in the treatment of SSNS. A clinical trial is needed to examine the efficacy of these medications to optimize treatment and decrease practice variation.

Keywords: Children; Practice variation; Prospective cohort; Steroid-sensitive nephrotic syndrome; Steroid-sparing medications.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

1. Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61–74. https://doi.org/10.1016/S0140-6736(18)30536-1 - DOI - PubMed
1. Downie ML, Gallibois C, Parekh RS, Noone DG (2017) Nephrotic syndrome in infants and children: pathophysiology and management. Paediatr Int Child Health 37:248–258. https://doi.org/10.1080/20469047.2017.1374003 - DOI - PubMed
1. Wang C-S, Greenbaum LA (2019) Nephrotic Syndrome. Pediatr Clin North Am 66:73–85. https://doi.org/10.1016/j.pcl.2018.08.006 - DOI - PubMed
1. McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 16:1040–1044. https://doi.org/10.1007/s004670100021 - DOI - PubMed
1. Chanchlani R, Parekh R (2016) Ethnic differences in childhood nephrotic syndrome. Front Pediatr 4:39. https://doi.org/10.3389/fped.2016.00039 - DOI - PubMed - PMC

Grants and funding

LinkOut - more resources

Full Text Sources
- Springer
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study

Affiliations

Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

References

Grants and funding

LinkOut - more resources

Full Text Sources

Miscellaneous

Abstract

Conflict of interest statement

Similar articles

References

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Miscellaneous